Sanofi Oncology announces new FDA approval

04 Aug 2012 8:41 PM | Lori Aubrey (Administrator)

NNECOS FDA Approval Page

Sanofi Oncology Anounces FDA Approval of Zaltrap for metastatic colorectal cancer

August 3, 2012: The U.S. Food and Drug Administration approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.


Read the FDA release.

Comments

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software